Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Justera Health Ltd C.VTAL

Alternate Symbol(s):  SCRSF

Justera Health Ltd. is a Canadian company focused on health and wellness. It offers personalized healthcare services and solutions, such as IV Vitamin Therapy, premium nutritional supplements through its Naturevan Nutrition brand, a full 360-degree wellness and spa experience through Juillet Wellness that provides registered massage therapy, acupuncture, and new retail stores in Vancouver. Its Concierge Medical business provides discreet and personalized concierge healthcare services, including IV Vitamin Therapy. Its services include Screenpro Security, Justera Health Product, Naturevan, Juillet Wellness, and TRINITI Corporation. It is also specialized in providing efficient COVID-19 testing and same-day test results through its Canadian labs. It offers two convenient methods to test: in clinic testing or mobile at home testing. It is a distributor of TonyMoly skin care products in Canada. It provides a full-service wellness center, providing a range of beauty and wellness services.


CSE:VTAL - Post by User

Comment by Smokey1958on May 19, 2021 7:24am
169 Views
Post# 33228391

RE:SCRN to Process Minimum 192,000 Tests for Q2-Q3-Q4 2021

RE:SCRN to Process Minimum 192,000 Tests for Q2-Q3-Q4 2021

I'm equally excited that expansion and diversifying is part of this abrupt and welcomed change in direction. While this news is good it represents half of what Screenpro did in February and 80% of what they did in March. So building on and building off of the current focus suggests their is a well thought out plan developing.

Having said that it still equates to about $2.5 million in revenue which would lead to a projection of at least $30 million in testing alone for 2021.

Moving into new testing niches and the potential for a definitive agreement on CENTRED bodes extremely well for SCRN .... especially since it's in it's infancy as a public company. WOW!

GLTE!!!

<< Previous
Bullboard Posts
Next >>